Dr. Berenika Maciejewicz, a triple-doctor and an expert in longevity, leads the company’s interdisciplinary team to ...
AN Oxbridge university student who studied at the Alun School has secured a top science prize in recognition of outstanding A-level results.
The Kenya Times on MSN
Open University of Kenya opens over 60 job opportunities for lecturers and drivers: How to ...
The Open University of Kenya has announced 61 job opportunities for academic and administrative staff positions. In a notice ...
Knotorious on MSN
How to tie the enzyme friction hitch for climbing on a rope!
This tutorial explains how to tie the Enzyme friction hitch for safe and efficient rope climbing, highlighting its smooth ...
Real-time index price for Nasdaq Biotechnology Index (NBI), along with buy or sell indicators, analysis, charts, historical performance, news and more ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
Healthcare and biotech stocks have had a rough run since the giddy heights of the Covid pandemic. But now could be the perfect time to consider investing in these beaten-down but high-growth sectors.
SIOUX FALLS, S.D. — In the northwest corner of Sioux Falls, an 80-acre campus opened its first building this year dedicated entirely to expanding the state's life science and biotechnology research ...
If you look at a stock chart mapping the performance of the State Street SPDR S&P Biotech exchange-traded fund since early 2021, it seems to tell a simple story: The biotech sector has been a disaster ...
Biotech-based exchange-traded fund (ETF) iShares Biotechnology ETF IBB has rallied about 35% over the past six months (as of Nov. 20, 2025), outperforming SPDR S&P 500 ETF Trust SPY (up 12%). Year to ...
Biotech stocks are emerging from a four-year slump. The SPDR S&P Biotech exchange-traded fund XBI, a proxy for the sector, is up 25% so far this year through Oct. 31, beating the S&P 500 SPX by 9 ...
Something unusual is happening to biotech stocks: They’re going up. A drug-pricing deal between Pfizer and the White House and a spate of deals have sent the SPDR S&P Biotech exchange-traded fund up 9 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果